Physitrack PLC
STO:PTRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (41.2), the stock would be worth kr6.9 (20% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 51.7 | kr8.66 |
0%
|
| 3-Year Average | 41.2 | kr6.9 |
-20%
|
| 5-Year Average | 16.7 | kr2.79 |
-68%
|
| Industry Average | 0.3 | kr0.05 |
-99%
|
| Country Average | 0.2 | kr0.03 |
-100%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
P
|
Physitrack PLC
STO:PTRK
|
140.8m SEK | 51.7 | -1.5 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 88.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 36.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.9B USD | 18.7 | 28.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.2B AUD | 118.2 | 60 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 23.9 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.7B SEK | 79.4 | 91.8 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD | 10.4 | 42.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 14.6 | 18.7 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
261.1B INR | -190 | 40.3 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 18.1 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.1 |
| Median | 0.2 |
| 70th Percentile | 0.4 |
| Max | 901.8 |
Other Multiples
Physitrack PLC
Glance View
Physitrack Plc engages in the provision of digital healthcare services for the business-to-business physiotherapy market. The firm is focused on providing technology to care providers and providing virtual-first wellness solutions to corporates. The firm operates through two business lines: Lifecare Technology and Virtual Wellness. Lifecare technology business line is a full-service offering built around Company’s software as a service (SaaS) solution. The company offers physiotherapy and musculoskeletal care, enabling practitioners to digitally deliver clinical home exercises, education prescription, outcomes tracking, triaging, and Telehealth. Its Virtual Wellness and care provision powered by the Champion Health technology platform and wellness professionals is based in the United Kingdom, Germany, and the Nordics. The firm's software features include exercise prescription and education, outcomes analysis, patient onboarding and triage, telehealth and messaging, collaboration and security and privacy.
